C5 and paroxysmal nocturnal hemoglobinuria: Clinical trial results have shown that iptacopan, similar to pegcetacoplan, effectively prevented IVH and EVH in patients with PNH who had chronic hemolysis with a C5 inhibitor, as shown by decreased LDH concentrations, increased hemoglobin concentrations, and reduced ARC [87].